DMK
IMVT icon

David M. Knott’s Immunovant IMVT Stock Holding History

David M. Knott’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$370K Sell
42,600
-54,694
-56% -$493K 0.13% 79
2021
Q2 		$1.03M Buy
97,294
+63,194
+185% +$882K 0.37% 54
2021
Q1 		$547K Buy
+34,100
New +$899K 0.23% 67

Other funds holding IMVT

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AGM
Alpine Global Management New York $615M AUM 34.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

David M. Knott's IMVT Position: Q3 2021 in Review

David M. Knott reduced its Immunovant (IMVT) stake by 56% in Q3 2021, selling an estimated $493K and leaving 42,600 shares worth $370K. The position accounts for 0.13% of the portfolio, ranked #79.

David M. Knott first reported a position in IMVT in Q1 2021 and has held it in 3 quarters since. The position peaked at $1.03M in Q2 2021. 119 funds tracked by Wall St. Rank hold IMVT as of Q3 2021.

  • David M. Knott held 42,600 shares of Immunovant worth $370K as of Q3 2021.
  • David M. Knott sold 54,694 Immunovant shares in Q3 2021, an estimated $493K.
  • Immunovant made up 0.13% of David M. Knott's portfolio in Q3 2021, its #79 holding.
  • David M. Knott first reported a position in Immunovant in Q1 2021 and has held it in 3 quarters since.
  • David M. Knott's Immunovant position peaked at $1.03M in Q2 2021.
  • 119 funds tracked by Wall St. Rank held Immunovant as of Q3 2021.

Based on David M. Knott's 13F filing for Q3 2021, filed 12 Nov 2021.